FDA Inspection 1008838 — Zhejiang Dingtai Pharmaceutical Co., Ltd
The FDA completed an inspection of Zhejiang Dingtai Pharmaceutical Co., Ltd on Mar 24, 2017 in Jia Xing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 24, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jia Xing (China)